azoxymethane has been researched along with thalidomide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gershbein, LL | 1 |
| Deng, F; Li, R; Liu, D; Lu, J; Tan, Y; Wang, X | 1 |
2 other study(ies) available for azoxymethane and thalidomide
| Article | Year |
|---|---|
The thalidomide analog, EM 12, enhances 1,2-dimethylhydrazine-induction of rat colon adenocarcinomas.
Topics: 1,2-Dimethylhydrazine; Adenocarcinoma; Animals; Azoxymethane; Body Weight; Carcinogens; Colon; Dimethylhydrazines; Drug Synergism; Intestinal Neoplasms; Intestine, Small; Male; Rats; Rats, Inbred Strains; Thalidomide | 1991 |
Thalidomide Attenuates Colitis and Is Associated with the Suppression of M1 Macrophage Polarization by Targeting the Transcription Factor IRF5.
Topics: Animals; Azoxymethane; Blotting, Western; Colitis, Ulcerative; Destrin; Epithelial Cells; Gene Expression Regulation; Humans; Interferon Regulatory Factors; Macrophages; Male; Mice; Plasmids; Real-Time Polymerase Chain Reaction; Thalidomide; THP-1 Cells; Transfection | 2021 |